Clinical trial
Citrate-based Regional Anticoagulation Versus Heparin for Continuous Renal Replacement Therapy in Critically Ill Patients With Acute Renal Failure: a Randomized Controlled Trial
NCT01269112 is registered in ClinicalTrials.gov with University Hospital, Geneva as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Citrate-based Regional Anticoagulation Versus Heparin for Continuous Renal Replacement Therapy in Critically Ill Patients With Acute Renal Failure: a Randomized Controlled Trial
- Lead sponsor
- University Hospital, Geneva
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- November 30, 2010
- Completion date
- November 30, 2013
- Enrollment
- 103 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.